EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Survival, ventricular arrhythmia, and implantable cardioverter‐defibrillator usefulness in toxic cardiomyopathy due to substance abuse

Nicolas Dognin, Goran Rimac, Guillaume Domain iD, Alexandre Cinq-Mars, Montse Massot, Pierre Yves Turgeon, Sacha-Michelle Dubois-Sénéchal, Christine Bourgault, Joëlle Morin, Mathieu Bernier, Jonathan Beaudoin, Maxime Laflamme und 6 weitere

Pacing and Clinical Electrophysiology · 2023

DOI: 10.1111/pace.14720 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pacing and Clinical Electrophysiology, 2023. Verfasst von Nicolas Dognin und 17 weiteren Autor:innen. Beteiligte Einrichtung: Département multidisciplinaire de cardiologie, Institut Universitaire de Cardiologie et de Pneumologie de Québec-Université Laval, Quebec City, Canad…. Hauptthemen laut MEDLINE: Defibrillators, Implantable, Cardiomyopathies, Cardiomyopathy, Dilated, Substance-Related Disorders. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Toxic dilated cardiomyopathy (T‐DCM) due to substance abuse is now recognized as a potential cause of severe left ventricular dysfunction. The burden of ventricular arrhythmias (VA) and the role of a prophylactic implantable cardioverter‐defibrillator (ICD) are not well documented in this population. We aim to assess the usefulness of ICD implantation in a T‐DCM cohort.

Methods

Patients younger than 65 years with a left ventricular ejection fraction (LVEF) < 35% followed at a tertiary center heart failure (HF) clinic between January 2003 and August 2019 were screened for inclusion. The diagnosis of T‐DCM was confirmed after excluding other etiologies, and substance abuse was established according to the DSM‐5 criteria. The composite primary endpoints were arrhythmic syncope, sudden cardiac death (SCD), or death of unknown cause. The secondary endpoints were the occurrence of sustained VA and/or appropriate therapies in ICD carriers.

Results

Thirty‐eight patients were identified, and an ICD was implanted in 19 (50%) of these patients, only one for secondary prevention. The primary outcome was similar between the two groups (ICD vs. non‐ICD; p = 1.00). After a mean follow‐up of 33 ± 36 months, only two VA episodes were reported in the ICD group. Three patients received inappropriate ICD therapies. One ICD implantation was complicated with cardiac tamponade. Twenty‐three patients (61%) had an LVEF ≥35% at 12 months.

Conclusion

VA are infrequent in the T‐DCM population. The prophylactic ICD benefit was not observed in our cohort. The ideal timing for potential prophylactic ICD implantation in this population needs further studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Defibrillators, ImplantableCardiomyopathiesCardiomyopathy, DilatedSubstance-Related DisordersHumansStroke VolumeVentricular Function, LeftArrhythmias, CardiacDeath, Sudden, CardiacRisk FactorsTreatment Outcome

Stichwörter der Autor:innen

arrhythmiacardiomyopathydrug abuseheart failureimplantable cardioverter-defibrillatorsudden cardiac death

Autor:innen und Institutionen

  • Département multidisciplinaire de cardiologie, Institut Universitaire de Cardiologie et de Pneumologie de Québec-Université Laval, Quebec City, Canada.

ORCID-Profile: Guillaume Domain, David Belzile

Zitieren

APA

Dognin, N., Rimac, G., Domain, G., Cinq-Mars, A., Massot, M., Turgeon, P. Y., Dubois-Sénéchal, S. M., Bourgault, C., Morin, J., Bernier, M., Beaudoin, J., Laflamme, M., Charbonneau, E., Strubé, C., Voisine, P., Philippon, F., Belzile, D., & Sénéchal, M. (2023). Survival, ventricular arrhythmia, and implantable cardioverter‐defibrillator usefulness in toxic cardiomyopathy due to substance abuse. Pacing and Clinical Electrophysiology. https://doi.org/10.1111/pace.14720

Vancouver

Dognin N, Rimac G, Domain G, Cinq-Mars A, Massot M, Turgeon PY, et al. Survival, ventricular arrhythmia, and implantable cardioverter‐defibrillator usefulness in toxic cardiomyopathy due to substance abuse. Pacing and Clinical Electrophysiology. 2023. doi:10.1111/pace.14720

BibTeX
@article{Dognin2023,
  author = {Dognin, Nicolas and Rimac, Goran and Domain, Guillaume and Cinq-Mars, Alexandre and Massot, Montse and Turgeon, Pierre Yves and Dubois-Sénéchal, Sacha-Michelle and Bourgault, Christine and Morin, Joëlle and Bernier, Mathieu and Beaudoin, Jonathan and Laflamme, Maxime and Charbonneau, Eric and Strubé, Camille and Voisine, Pierre and Philippon, François and Belzile, David and Sénéchal, Mario},
  title = {Survival, ventricular arrhythmia, and implantable cardioverter‐defibrillator usefulness in toxic cardiomyopathy due to substance abuse},
  journal = {Pacing and Clinical Electrophysiology},
  year = {2023},
  doi = {10.1111/pace.14720}
}
Kostenlos starten →